KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Liabilities and Shareholders Equity (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $405.9 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 1.6% to $405.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 1.45% year-over-year, with the annual reading at $405.9 million for FY2025, 1.6% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $405.9 million at Biolife Solutions, up from $392.1 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $559.4 million in Q3 2021, with the low at $240.0 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $433.5 million, with a median of $411.9 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity surged 357.11% in 2021, then decreased 18.77% in 2022.
  • Over 5 years, Liabilities and Shareholders Equity stood at $554.3 million in 2021, then decreased by 18.77% to $450.2 million in 2022, then decreased by 8.33% to $412.7 million in 2023, then dropped by 3.2% to $399.5 million in 2024, then increased by 1.6% to $405.9 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $405.9 million, $392.1 million, and $387.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.